The Cecropia genus consists of about 60 species distributed throughout Latin America, mostly in Brazil. These species are widely used in traditional medicine to treat cough, asthma, bronchitis, high blood pressure, inflammation, heart disease, and as a diuretic. In recent years, there has been an increase in research on Cecropia species, with several phytochemical and pharmacological reports. Concerning its chemical composition, C-glycosylflavonoids and proanthocyanidins have been described as the main constituents of C. glaziovii, C. hololeuca and C. pachystachya, while terpenoids and steroids have been reported in several species, including C. adenopus and C. pachystachya. Among the pharmacological properties described for the genus, the most frequently reported are hypoglycemic activity for C. obtusifolia and C. peltata, and hypotensive and central nervous system activity for C. glaziovii. The present review compiles the information available on this genus because of its ethnopharmacological relevance and the potential therapeutic uses of these species.
C. pachystachya occurs in different ecosystems of Brazil, such as Atlantic Forest, Wetland and Savannah [1] . However, some researchers disagree on the correct classification of the species occurring in southern Brazil, which was described by J.P.P. Carauta as a new species, C. catarinensis [15] . On the other hand, the results of chemical analyses carried out by our research group on different Brazilian samples collected in the South (Viamão/RS) and Center-West (Campo Grande/MS and Campo Verde/MT) regions did not show any qualitative differences in the chemical fingerprint of aqueous extracts of these samples when analyzed by thin-layer chromatography and high-performance liquid chromatography [16] .
Thus, the results did not demonstrate the occurrence of a new species in the Brazilian South region, but more likely, the presence of the same species C. pachystachya, in accordance with taxonomic studies [1, 17] . Several ethnopharmacological reports are described in the literature. The popular uses of the different species, mainly as tea, are recommended for the treatment of respiratory diseases [2, 14, [18] [19] [20] , high blood pressure [2, 14, 17, 18] and glycemic control [14] , with emphasis on the widespread use of C. obtusifolia ('guarumbo') for the treatment of diabetes mellitus [21, 22] , and C. glaziovii ('embaúba') for control of high-blood pressure and as a diuretic [23] .
Besides their use in traditional medicine, the barks of different species are also used in the leather tanning industry, due to their high tannin content, while the wood is used in cellulose production and in the construction of boxes and boats [1] . The use of the trees in deforestation areas is also described, due to their rapid growth, which has also helped distribute these species over several regions of Brazil [17, 24] .
Chemical constituents
Of the 60 Cecropia species, the chemical composition has been reported for only ten. The most commonly described substances are terpenoids, steroids [25] [26] [27] and phenolic compounds, such as proanthocyanidins and flavonoids [28, 29] .
Of the terpenoids (Figure 1 ), β-sitosterol and ursolic acid are reported for several species, such as C. adenopus [30] , C. pachystachya [25, 31] , C. pupurascens [32] , C. palmata [33] and C. obtusa [34] . For C. pachystachya, pomolic and oleanolic acids, α-amyrin and 19-α-hydroxy-α-amyrin [25] , sitostenone and tormentic acid [31, 35] have been isolated. For C. palmata, pomolic acid, α-amyrin, β-amyrin and derivatives of stigmasterol are reported in its composition [33] . For C. obtusa, β-amyrinone and derivatives of oleanolic and ursolic acids [34] are recorded.
For C. lyratiloba, euscaphic, tormentic, 2α-acetyltormentic and 3β-acetyltormentic acids [26, 27] are described. Three triterpenes, 2α-acetoxy-3β,19α-dihydroxy-11α,12αepoxy-ursan-28,13β-olide, 3β-acetoxy-2α,19α-dihydroxy-11α,12α-epoxy-ursan-28,13β-olide and 2-O-acetyleuscaphic acid, besides oleanolic acid, ursolic acid and derivatives, have been isolated from C. catharinensis [36] . Palmitic, stearic and vanillic acids, together with stigmast-4-en-3-one, 4-cholestene-3,24-dione, 4,22-cholestadien-3one, 4-vinyl-2-methoxy-phenol, 2-methylbenzaldehyde, 2,3-dihydrobenzofuran, and 3'-methoxyacetophenone have been identified in C. obtusifolia [37] .
For the flavonoids ( Figure 2 ), orientin (1), isoorientin (2) and isovitexin (3) are reported for C. glaziovii, C. pachystachya [28, 38] and C. lyratiloba [39] , orientin and isoorientin for C. hololeuca [38] and C. adenopus [40] , and isoorientin for C. obtusifolia [41] . Vitexin (4) and rutin (5) are also recorded for C. adenopus [40] . For C. lyratiloba, a C-glycosylflavone 6-C-galactosyl-6"-O-βgalactopyranoside (6) [39] has been identified, while for C. glaziovii and C. pachystachya, the flavonoid O-heteroside isoquercetrin (7) [28] is reported.
The proanthocyanidins ( Figure 3 ) catechin, epicatechin and procyanidins B2 and C1 have been identified from C. glaziovii, C. hololeuca and C. pachystachya [28] . For C. glaziovii, procyanidins B3 and B5 [29] are reported. Other phenolic compounds described are protocatechic acid for C. hololeuca and C. pachystachya, and chlorogenic acid for C. glaziovii, C. hololeuca, C. pachystachya [28] , C. obtusifolia [41] and C. peltata [42] , as well as scopoletin for C. palmata [33] .
Quantitative studies by HPLC were described for C. glaziovii and C. pachystachya. Quantification of the major constituents of a standardized aqueous extract from the leaves of C. glaziovii showed 12% catechins, 19% procyanidins and 19% total flavonoids [29] . Chlorogenic and caffeic acids were quantified in C. glaziovii leaves using different extractions procedures. Extracts with 80% ethanol presented a higher chlorogenic acid content, while extracts with 20% ethanol showed a higher caffeic acid concentration [43] . Additionally, quantification of the major phenolic compounds in the leaves of C. glaziovii and C. pachystachya showed that chlorogenic acid is the major compound in the aqueous extract of both species, while isovitexin was the main C-glycosylflavonoid for C. glaziovii and isoorientin the main one for C. pachystachya [44] . 
Pharmacological properties
Pharmacological studies have been described mainly for C. glaziovii, C. obtusifolia and C. pachystachya. In general, the reports are of pre-clinical investigations, and there have only been two clinical studies. Table 1 summarizes the pharmacological activities reported.
Cardiovascular activities:
Evaluation of the hypotensive activity of C. glaziovii aqueous extract by oral intake in rats showed that this effect occurs by relaxing the smooth muscle, through two mechanisms: blockade of type 1 calcium-channels on smooth muscles, and effect on β-2 adrenergic receptors [45] . Dichloromethane/methanol and methanol extracts of the leaves of this species showed, in vitro, inhibition of Angiotensin Conversion Enzyme (ACE) [28, 46] . The leaves, barks and stipules of C. glaziovii, C. hololeuca and C. pachystachya also present in vitro ACE inhibition, this activity being due to a possible synergism between C-glycosylflavonoids and proanthocyanidins, as these compounds were inactive when isolated [28] .
However, evaluation of the inhibitory effects on ACE in vivo by the aqueous extract of C. glaziovii showed that a single administration of the extract did not alter the activity of this plasma enzyme, blood pressure, or heart rate. On the other hand, repeated administrations of the extract reduced blood pressure after 14 days of treatment, without any alteration of ACE activity [47] . In addition, the same researchers showed a reduction in blood pressure in normotensive and hypertensive rats after chronic administration of aqueous extract and its butanolic fraction, an activity that is independent of ACE inhibition, oxide nitric synthesis, and specific α1 or AT 1 receptor blockade [48] .
Aqueous extracts of C. pachystachya, collected from different regions, were assayed for their cardiovascular effects in rats [49] . The sample collected in a neotropical region (Misiones/Argentina) resulted in a higher hypotensive activity, while the sample collected in a temperate region (Córdoba/Argentina) produced a significant increase in heart rate. These effects are attributed to a central inhibition of the autonomic nervous system, which explains the hypotension by sympathic blockade on the vessels and the tachycardia by vagal inhibition of the heart. Further studies have demonstrated cardiotonic effects of aqueous extracts from the same species in isolated heart [50] .
Methanol extracts of C. lyratiloba and its flavonoidenriched fraction produced dose-dependent vasodilation of the aorta. However, the major flavonoids identified in the extract, isoorientin, orientin and isovitexin, did not show this activity when tested individually [51] .
Acid and neutral fractions of the dichloromethane and methanol extracts from C. obtusifolia leaves produced vasorelaxant effects on aortic rings. However, none of the fractions reduced the amplitude of angiotensin IIcontraction on the endothelium-intact aortic preparations isolated from spontaneously hypertensive rats [37] .
Hypoglycemic activity: Studies of hypoglycemic activity of C. obtusifolia until 2005 were previously reviewed by Andrade-Cetto and Heinrich [21] . Previously, this group had evaluated the hypoglycemic activity of aqueous and butanolic extracts of the leaves of C. obtusifolia and their major compounds (isoorientin and chlorogenic acid) in diabetic rats, induced by streptozotocin (STZ). The extracts and isolated compounds significantly reduced glucose levels three hours after oral intake [41] .
Another study showed that the hypoglycemic effects of methanol extracts of C. obtusifolia and C. peltata are correlated with their chlorogenic acid content. C. peltata 916 Natural Product Communications Vol. 6 (6) 2011
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showed a greater reduction in glucose level in non-diabetic rats, as well as a higher chlorogenic acid content than for C. obtusifolia, suggesting a linear correlation between hypoglycemic activity and chlorogenic acid content in the species [42] . However, in another study with STZ diabetic rats [52] , an aqueous extract of C. peltata showed lower hypoglycemic activity than that observed in a previous study with C. obtusifolia [41] .
The mechanism of this activity was investigated by evaluation of the inhibitory effect of a butanolic extract of C. obtusifolia on -glycosidase. In vivo, the extract reduced plasma glucose 90 minutes after sample intake and in vitro showed a high degree of inhibition of -glycosidase [53] . Another investigation of the mechanism of action demonstrated an increase in in vitro glucose reuptake, both in insulin-sensitive and insulinresistant adipocytes when treated with an aqueous extract of C. obtusifolia and with chlorogenic acid [54] . Recently, it was reported that aqueous and butanolic extracts of C. obtusifolia and C. peltata, administrated orally, reduced hepatic glucose production in vivo and inhibited the activity of the enzyme glucose-6-phosphate translocase in vitro, which could also explain the glycemic control observed [55] .
Hypoglycemic activity is also reported for C. pachystachya. The methanol extract of the leaves of this species showed a significant hypoglycemic effect in diabetic rats. However, in normal rats, no significant blood glucose reduction was observed. An acute effect was also described for diabetic rats, which was more pronounced at 90 minutes. The authors suggest that chlorogenic acid and flavonoids (isoorientin and orientin), identified in the extract, could be responsible for the effects observed [38] .
Central nervous system activities:
Behavior assays, such as for sedative, anxiolytic-like and antidepressant-like activities were performed with three species of Cecropia. Depressor effects were observed for the aqueous extract of C. obtusifolia leaves, which reduced the exploratory and evasive capacity in mice, and promoted significant motor incoordination and muscle relaxant effects [56] . For C. pachystachya, aqueous extracts of the leaves from two different regions induced sedative effects in mice, an effect that was not antagonized by flumazenil administration [50] .
Aqueous extract of the leaves of C. glaziovii did not produce anxiolytic effects in rats after single-dose treatment, but only in sub-chronic treatment. The butanolic fraction was 10 times more active than that of the aqueous crude extract [57] . Furthermore, the same group evaluated the antidepressant activity of C. glaziovii in vivo, and also ex vivo and in vitro. Biomonitored assay showed that the activity observed in vivo is related to blockade of monoamine reuptake to the central nervous system, mainly of noradrenaline, suggesting that catechin, procyanidin B3 and procyanidin B2 are the most activities compounds [58] .
Anti-inflammatory activity:
Two species were tested for their potential anti-inflammatory effects in vivo. The nhexane extract from C. pachystachya produced significant anti-inflammatory effects in the model of rat paw edema induced by carrageenan, with isolated -sitosterol being the most active compound [25] . Recently, antiinflammatory activity was also observed for the dichloromethane extract and its isolated compound pomolic acid [59] . Aqueous extract of C. obtusifolia showed topical and systemic anti-inflammatory activity (per oral) in two models of edema: ear edema induced by TPA (12-O-tetradecanoylphorbol acetate), and paw edema induced by carrageenan [56] .
Other pharmacological activity: Antiviral activity in vitro
was reported for C. glaziovii against the human herpes virus types 1 and 2. This activity was observed for the aqueous crude extract, butanolic fraction and in particular, a C-glycosylflavonoid-enriched fraction, with isovitexin and isoorientin as the major compounds from this fraction. The possible mechanisms of action are a reduction in viral infectivity against type-2 virus, inhibition of entry into the cells and viral cell-to-cell spread for both virus types and also by the impaired levels of envelope proteins of herpes virus type 1 [60] .
Standardized aqueous extract and a butanolic fraction [29] of C. glaziovii showed brochodilation activity in pigs by oral administration, causing a reduction in bronchospasms induced by histamine and tracheal muscle relaxation, probably due to a -adrenergic agonist effect [61] . The same extract and fraction inhibited gastric acid secretion and produced an antiulcer effect in mice, with a possible mechanism related to inhibition of the gastric proton pump [62] .
In vitro assays with the dichloromethane/methanol extract of the stems and leaves of C. obtusifolia showed inhibition of [ 3 H]-AT II binding (angiotensin II AT 1 receptor), and the 80% ethanol extract of the stems and leaves of the same species showed high inhibition of [ 3 H] BQ-123 binding (endothelin-1 ET A receptor) [63] . Aqueous extract of the same species presented significant analgesic activity, with effect in models of chemical induced pain (acetic acid and formalin), but not with thermal stimuli, which suggests a peripheral analgesic effect [56] .
The methanol extract of C. pachystachya showed inhibition of lipid peroxidation activity in enzymatic and non-enzymatic systems, and also scavenging activity on DPPH radicals [38, 64] . For C. palmata, a hydroalcoholic extract presented antioxidant activity in both the ORAC assay (oxygen radical antioxidant capacity) and the TEAC assay (trolox equivalent antioxidant capacity) [65] .
The pentacyclic triterpenes tormentic acid, euscaphic acid, 2-acetyltormentic acid and 3-acetyltormentic acid, isolated from the roots of C. lyratiloba [26] were cytotoxic to leukemia cells, including multidrug resistant cell lines, inducing cell death by activation of capase-3 in an apoptotic pathway [27] . Ethanol extract from the wood, roots and leaves of C. pachystachya presented antimalarial activity against Plasmodium falciparum and P. berguei. Two compounds isolated from the roots, -sitosterol and tormentic acid, also reduced parasitemia of P. berguei in vivo, but only tormentic acid showed activity in vitro against chloroquine-resistant P. falciparum [31] .
A triterpenoid-enriched fraction from C. adenopus showed blocking action on the calcium channels in the uterine 918 Natural Product Communications Vol. 6 (6) 2011
smooth muscles [30] . For C. purpurascens, antileishmania activity is reported, by the inhibition of the growth of the promastigote form of Leishmania amazonensis [32] . For C. peltata, there are reports of its wound-healing effects in rats by oral intake of aqueous extract and topical application of the ethanol extract [66] .
Clinical trials: Studies on human patients are described only for C. obtusifolia. Daily intake of aqueous extract of the leaves by 22 patients with poor response to conventional treatment with oral hypoglycemic drugs, for a period of 21 days, resulted in a significant reduction in glucose levels, together with a decrease in cholesterol and triglyceride values [67] . Another clinical trial with 12 patients recently diagnosed as diabetic type 2, lasting 32 weeks, showed a significant and sustainable hypoglycemic effect after 18 weeks of daily intakes of C. obtusifolia extract, an effect that was maintained 4 weeks after the end of the treatment [68] . There were no changes in the patients' insulin levels, which suggest that the hypoglycemic effect is not correlated to insulin secretion.
Toxicity information: Genotoxicity of C. obtusifolia extracts was evaluated, and the results showed that the aqueous extract did not induce either somatic mutations or mitotic recombination in Drosophila melanogaster by the SMART assay, at concentrations of between 0.83 and 13.32 mg/mL, and also showed neither cytotoxic nor genotoxic effects in the lymphocytes of six type-2 diabetic patients treated daily with 13.5 g of extract for 85 days [69] . The effects on physical and neurobehavioral development of mice treated with C. glaziovii extract (1.0 g/kg/day) during the gestational period revealed a DL 50 higher than 5.0 g/kg. Also, extract administration did not significantly affect the physical and neurobehavioral development of pups [70] . Another study also showed no acute toxicity until 0.9 g/kg of crude hydroalcoholic extract of the leaves of C. glaziovii, and no clastogenic and aneugenic activity of the extract, evaluated on root meristematic cells of Allium cepa, suggesting that the extract does not interfere with cell division [71] . Investigations of either toxicity or behavior changes in mice caused by administration of aqueous extracts of C. pachystachya (0.76 g/kg) showed that the crude extract does affected feeding, body weight, or organ morphology, and does not promote toxicity in the broncheoalveolar fluid. Also non-anxiolytic-like activity was observed [72] .
Final considerations: Most of the chemical and pharmacological studies described in the literature on Cecropia species refer to C. glaziovii, C. obtusifolia and C. lyratiloba. The major compounds of several active extracts have been identified as phenolic compounds, such as C-glycosylflavonoids and proanthocyanidins. Some of these secondary metabolites (such as orientin, isoorientin, catechin, epicatechin) occur concomitantly in different species, including C. glaziovii, C. hololeuca and C. pachystachya.
Concerning the pharmacological activities, there is scientific evidence that C. glaziovii extract has antihypertensive activity, blocking the calcium channel in the smooth muscle. The antidepressant activity observed for this species is related to the presence of procyanidins B2, B3 and catechin, which bind serotonin, dopamine and noradrenalin reuptake. In the case of C. obtusifolia, its hypoglycemic activity is widely described in the literature. This effect is attributed to isoorientin and chlorogenic acid, and the probable mechanisms are the inhibition of glycosidase and an increase in glucose reuptake by the adipocytes. In an overview, among the various species of Cecropia, only a few have been studied chemically and/or pharmacologically. Even so, the genus Cecropia is very promising pharmacologically, as seen in pre-clinical assays, in activities such as cardiovascular, hypoglycemic, anxiolytic and antidepressant-like. Clinical studies are still rare and, so far, only clinical trials on the hypoglycemic activity of C. obtusifolia have been reported.
Future studies, both chemical and pharmacological, should be conducted with Cecropia species, in order to obtain evidence for their activities, including in humans, and corroborate with their several ethnopharmacological reports.
